(291722), N. R., (325054), A. A., (12221192), J. R. L., (3505712), S. P., (9718733), R. J. M., (19482394), D. K. Y., . . . (291723), P. J. T. (2022). Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(291722), Naila Rabbani, et al. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. 2022.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(291722), Naila Rabbani, et al. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. 2022.